VRTX
Vertex Pharmaceuticals Inc / MaCompany with tickers: VRTX
CIK
875320
CUSIP
92532F100
Shares Outstanding
253,805,417
13F Activity (30d)
600 filings
559 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization. Amounts come exclusively from tagged SEC data, so periods a company never tagged show no figure.
Program Authorized
$4,000,000,000
as of 2025-05-31
Remaining Authorization
$3,000,000,000
as of 2026-03-31
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 YTD | $336,900,000 | 10-Q, filed 2026-05-05 |
| 2025-12-31 | $2,017,400,000 | 10-K, filed 2026-02-13 |
| 2024-12-31 | $1,177,100,000 | 10-K, filed 2026-02-13 |
| 2023-12-31 | $427,600,000 | 10-K, filed 2026-02-13 |
| 2022-12-31 | $0 | 10-K, filed 2025-02-13 |
| 2021-12-31 | $1,425,400,000 | 10-K, filed 2024-02-15 |
| 2020-12-31 | $539,100,000 | 10-K, filed 2023-02-10 |
| 2019-12-31 | $186,000,000 | 10-K, filed 2022-02-09 |
| 2018-12-31 | $350,043,000 | 10-K, filed 2021-02-11 |
| 2017-12-31 | $0 | 10-K, filed 2020-02-13 |
| 2016-12-31 | $0 | 10-K, filed 2019-02-13 |
Recent quarters
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 | $336,900,000 | 10-Q, filed 2026-05-05 |
| 2025-12-31 | $128,400,000 Δ | 10-K, filed 2026-02-13 |
| 2025-09-30 | $1,071,100,000 Δ | 10-Q, filed 2025-11-04 |
| 2025-06-30 | $391,800,000 Δ | 10-Q, filed 2025-08-05 |
| 2025-03-31 | $426,100,000 | 10-Q, filed 2026-05-05 |
| 2024-12-31 | $417,900,000 Δ | 10-K, filed 2026-02-13 |
| 2024-09-30 | $307,700,000 Δ | 10-Q, filed 2025-11-04 |
| 2024-06-30 | $320,300,000 Δ | 10-Q, filed 2025-08-05 |
| 2024-03-31 | $131,200,000 | 10-Q, filed 2025-05-06 |
| 2023-12-31 | $149,500,000 Δ | 10-K, filed 2026-02-13 |
| 2023-09-30 | $117,000,000 Δ | 10-Q, filed 2024-11-05 |
| 2023-06-30 | $28,300,000 Δ | 10-Q, filed 2024-08-02 |